SPOTLIGHT -
Case Study: Use of Disease-Modifying Therapy in Elderly Patients With Multiple Sclerosis
With the advent of disease-modifying therapies, the life span of patients with multiple sclerosis has increased dramatically.
Read More
Case Study: The Pharmacist’s Role in Atopic Dermatitis Treatment
The goals of therapy for atopic dermatitis include reducing symptoms of pruritis and dermatitis with disease control and prevention of flares.
Oncology Overview: Adagrasib (MRTX849) for Non-Small Cell Lung Cancer
The FDA is evaluating the use of adagrasib (MRTX849) to treat patients with non-small cell lung cancer harboring a KRAS G12C mutation who have previously received at least 1 systemic therapy.
Oncology Overview: Poziotinib for Non-Small Cell Lung Cancer
Poziotinib is an irreversible pan HER2 inhibitor with activity against mutations of HER1, HER2, and HER4.
Oncology Overview: Inqovi for Myelodysplastic Syndrome
The FDA approved decitabine/cedazuridine in 2020 for treatment of adults with myelodysplastic syndromes.